The Editor-in-Chief is a member of the International Society of Addiction Journal Editors
Aims and Scope
The Journal of Cannabis Research is an international, fully open access, peer-reviewed journal that welcomes submissions covering all topics pertaining to cannabis. Our goal is to provide an outlet for experts across disciplines and foster innovation and collaboration, driving public discourse around this timely issue and furthering this exciting area of research.
Read the aims and scopeThe Two Sides of Hemp
Section Editor for Agriculture and Plant Biology, Dr Nirit Bernstein, is pleased to launch a collection titled, "The Two Sides of Hemp: Medical and Industrial". We cover hemp plant science; chemistry and cultivation; ethnobotany and regulations; medical and industrial uses of hemp and hemp products (such as cannabidiol); and differences between hemp and psychoactive cannabis.
-
-
Comment on āHall et al., Topical cannabidiol is well tolerated in individuals with a history of elite physical performance and chronic lower extremity painā
-
A national study of clinical discussions about cannabis use among Veteran patients prescribed opioids
-
Evaluation of dispensariesā cannabis flowers for accuracy of labeling of cannabinoids content
-
Oral Cannabis consumption and intraperitoneal THC:CBD dosing results in changes in brain and plasma neurochemicals and endocannabinoids in mice
-
Processing and extraction methods of medicinal cannabis: a narrative review
-
Delta-8-THC: Delta-9-THCās nicer younger sibling?
-
Cannabis consumption is associated with lower COVID-19 severity among hospitalized patients: a retrospective cohort analysis
-
Ī9-Tetrahydrocannabivarin (THCV): a commentary on potential therapeutic benefit for the management of obesity and diabetes
-
Total and differential white blood cell count in cannabis users: results from the cross-sectional National Health and Nutrition Examination Survey, 2005ā2016
Why publish with us?
Achieve high impact with a broad audience and publish in the leading open access cannabis research journal
- Impact Factor of 3.7, CiteScoreā¢ of 3.5 and mean 6.5k downloads/article
- Truly multidisciplinary covering all aspects of cannabis and led by an esteemed Editorial Board
- Broadly indexed and highly discoverable, including PubMed Central, Scopus, Web of Science and more...
Check our article-processing charges and find out how to get supported.
Truly multidisciplinary
Our journal welcomes all aspects of cannabis research, divided into the following sections:
- Agriculture and plant biology
- Commerce, business, and environment
- Endocannabinoid system
- Cannabis and cannabinoids biochemistry and genetics
- Cannabis and cannabinoids preclinical pharmacology
- Cannabis and cannabinoids clinical pharmacology
- Epidemiology and public health
- Cannabis-related disorders
- Medical cannabis
- History, regulation, and public policy
In Memoriam: Raphael Mechoulam
It is with great sadness that the Journal of Cannabis Research report the death of world-renowned cannabis researcher and our valued editorial board member, Raphael Mechoulam, PhD, on March 9, 2023.
Read a tribute from our Editor-in-Chief.
About the Institute
The Journal of Cannabis Research is the official publication of the Institute of Cannabis Research (ICR), which was established in June 2016 through an innovative partnership between Colorado State University Pueblo, the state of Colorado, and Pueblo County.
The ICR is the first US multi-disciplinary cannabis research center at a regional, comprehensive institution. The primary goal of the ICR is to conduct or fund research related to cannabis and publicly disseminate the results of the research, which it does so in partnership with the Journal. It also advises other Colorado-based higher education institutions on the development of a cannabis-related curriculum and supports the translation of discoveries into innovative applications that improve lives.
Find out more about the the Institute via the link below, as well as the Colorado state UniversityāPueblo website and Institute's research funding outcomes.
Visit the websiteAbout the Editor-in-Chief
David A. Gorelick, MD, PhD, DLFAPA, is Professor of Psychiatry (part-time) at the University of Maryland School of Medicine, having retired in October 2013 from the Intramural Research Program of the National Institute on Drug Abuse (NIDA), US National Institutes of Health (NIH) in Baltimore, Maryland.
Dr Gorelick's research interests are the clinical pharmacology of substance use, substance withdrawal, and biological treatments of substance use disorders. His recent work focuses on cannabis (including its potential therapeutic uses), cocaine, and individuals with co-morbid psychiatric disorders.
Read moreAffiliated with
āāāāāāāAn official publication of the Institute of Cannabis Research
Annual Journal Metrics
-
2022 Citation Impact
3.7 - 2-year Impact Factor
3.4 - 5-year Impact Factor
0.741 - SNIP (Source Normalized Impact per Paper)2023 Speed
21 days submission to first editorial decision for all manuscripts (Median)
211 days submission to accept (Median)2023 Usage
596,678 downloads
1,834 Altmetric mentions